This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Van Besien, Koen
| Item Type | Name |
|
Concept
|
Multiple Myeloma
|
|
Academic Article
|
Regulation of myeloma cell growth through Akt/Gsk3/forkhead signaling pathway.
|
|
Academic Article
|
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.
|
|
Academic Article
|
Controversies in multiple myeloma: to transplant or not?
|
|
Academic Article
|
Thiotepa, busulfan, and cyclophosphamide: a new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myeloma.
|
|
Academic Article
|
A phase 1 study of bendamustine and melphalan conditioning for autologous stem cell transplantation in multiple myeloma.
|
|
Academic Article
|
Reduced duration of cytopenias following melphalan conditioning and autografting for multiple myeloma.
|
|
Academic Article
|
Arterial thrombosis in four patients treated with thalidomide.
|
|
Academic Article
|
Lenalidomide after stem-cell transplantation for multiple myeloma.
|
|
Academic Article
|
Phase I trial of cyclosporine-induced autologous graft-versus-host disease in patients with multiple myeloma undergoing high-dose chemotherapy with autologous stem-cell rescue.
|
|
Academic Article
|
Reduced-intensity and nonmyeloablative conditioning regimens.
|
|
Academic Article
|
Statement of Retraction: Huang H, Wu D, Fu J, Chen G. "multiple myeloma cells undergo differentiation upon exposure to rosiglitazone and all-trans retinoic acid".
|
|
Academic Article
|
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia.
|
|
Academic Article
|
A Phase I Trial of High-Dose Lenalidomide and Melphalan as Conditioning for Autologous Stem Cell Transplantation in Relapsed or Refractory Multiple Myeloma.
|
|
Academic Article
|
Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial.
|
|
Academic Article
|
Validating and implementing the use of an infusion pump for the administration of thawed hematopoietic progenitor cells-a single-institution experience.
|
|
Academic Article
|
Comparison of time to engraftment between autologous patients receiving washed versus non-washed cryopreserved peripheral blood stem cell products.
|
|
Academic Article
|
Bortezomib and Immune Globulin Have Limited Effects on Donor-Specific HLA Antibodies in Haploidentical Cord Blood Stem Cell Transplantation: Detrimental Effect of Persistent Haploidentical Donor-Specific HLA Antibodies.
|
|
Academic Article
|
High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma.
|